Will the NHI cover Ozempic, Wegovy or Mounjaro once it's fully implemented?

South Africa's National Health Insurance is still being phased in, and the specific medicine formulary that will apply under full NHI implementation has not been finalised publicly at the level of detail patients would need to plan around. It's reasonable to expect that, as with the current public system, any future coverage would likely prioritise diabetes management and other medically indicated uses over weight loss alone, similar to how many private medical aid formularies work today. Patients should follow official Department of Health and NHI communications rather than assuming coverage, and shouldn't delay other treatment plans while waiting for clarity.

What are my options if I can't access or afford GLP-1 medication right now?

If GLP-1 medication isn't accessible or affordable, that doesn't mean weight management options are unavailable. A structured eating plan (our Banting, intermittent fasting and portion-based guides are free), regular physical activity, addressing sleep and stress, and working with your local clinic sister or state-sector doctor on realistic goals can all produce meaningful results without medication. Some patients also explore private medical aid chronic medication benefits, compare pharmacy prices, or ask their doctor about more affordable diabetes medications that may have secondary weight benefits.

Where can I get reliable, current information on NHI and medicine access?

The National Department of Health and SAHPRA (South African Health Products Regulatory Authority) are the official sources for NHI implementation updates and medicine registration status. Because NHI rollout details and provincial formularies can change, it's worth checking these official channels directly, or asking your local clinic, rather than relying on social media or word-of-mouth claims about what is or isn't covered.

NHI & Public Healthcare GLP-1 Access in South Africa: What Patients Should Know

Q: Can I get Ozempic or Wegovy for free at a state clinic or hospital in South Africa?

Public sector access to GLP-1 medications is currently very limited and varies by province and facility. Where these medicines are available in the state system, they are generally prioritised for patients with type 2 diabetes managed through provincial essential medicines lists and hospital formularies, rather than for weight loss alone. Availability, brand and dosage can differ between provinces and even between hospitals, so the only reliable way to know what's accessible at your nearest facility is to ask your local clinic or hospital pharmacy directly.

By Weight Loss Diets SA | Updated July 2026 | 8 min read

With Ozempic, Wegovy, Mounjaro and similar GLP-1 medications dominating weight loss headlines, it's natural for South Africans who rely on state healthcare or are following NHI (National Health Insurance) developments to ask: will I ever be able to get this through the public system? It's a fair question with a genuinely complicated answer, because it sits at the intersection of an evolving national health reform, provincial hospital formularies, and a class of medicines that remains expensive and in variable supply even in the private sector. Here's a realistic look at where things stand, without overpromising.

Key point: Public sector and future NHI access to GLP-1 medications is still developing and details aren't finalised. Where these medicines are accessible in state facilities today, it's generally tied to diabetes management rather than weight loss alone -- similar to how most private medical aid formularies currently work.

What's Realistically Available at State Clinics and Hospitals Today

South Africa's public healthcare system works through provincial essential medicines lists and hospital formularies, which determine which medicines are stocked and funded at state facilities. Where GLP-1 or related diabetes medications appear on these lists, they are typically prioritised for patients with confirmed type 2 diabetes, managed according to clinical guidelines, rather than being available for weight loss in the absence of diabetes. Availability, specific medicines and dosages can differ meaningfully between provinces and even between individual hospitals or clinics, so there's no single national answer -- the only reliable way to find out what's accessible near you is to ask directly at your local clinic or hospital pharmacy, or your treating doctor if you're already a public sector patient.

If you're managing type 2 diabetes through the public system already, it's worth discussing your specific treatment options with your clinic doctor or diabetes nurse educator, since medication decisions are made based on your clinical picture, not just what's trending in the media.

Where NHI Stands and What It Means for Medicine Access

The National Health Insurance is a long-term, phased health financing reform intended to move South Africa toward universal health coverage over time. As it continues rolling out, the detailed medicine formulary that will eventually apply under full implementation has not been finalised publicly at the level of specificity patients need to plan around -- and this is a fast-moving policy area, so anything written today can be outdated within months. What's reasonable to expect, based on how public formularies and most private medical aid schemes currently approach these medicines, is that future coverage decisions are likely to prioritise medically indicated uses like diabetes management over weight loss alone, at least initially.

Follow official sources: For current, accurate information on NHI implementation and medicine coverage, check the National Department of Health and SAHPRA directly rather than relying on social media claims or word-of-mouth, which can spread outdated or inaccurate information quickly.

How This Compares to Private Medical Aid Access

It's worth knowing that even in the private sector, GLP-1 access isn't automatic or universal. Most private medical aid schemes that fund these medicines do so through chronic medication benefits tied to a diagnosis like type 2 diabetes, and often require specific clinical criteria, prior authorisation, or apply them only above certain BMI thresholds when weight loss is the primary goal. Our GLP-1 medical aid coverage guide breaks down how major SA schemes currently approach this, and our Ozempic cost guide covers current self-funded pricing if medical aid or public access isn't an option for you right now.

What to Do While Access Develops

If GLP-1 medication isn't currently accessible or affordable for you -- whether through the public system, NHI, or private medical aid -- that doesn't mean effective weight management is out of reach. A few practical directions worth exploring:

Structured, sustainable eating plans -- our Banting/LCHF guide and intermittent fasting guide are free and don't require medication
Regular physical activity, built around what's accessible to you -- walking, home workouts, or community sports programmes
Working with your local clinic sister, state doctor or dietitian on realistic, personalised goals rather than comparing yourself to medication-assisted results you've seen online
Asking about other affordable diabetes medications if you have type 2 diabetes -- some older, well-established options are more widely available in the public system and may have modest secondary weight benefits
Checking your specific medical aid's chronic benefit list annually, since formularies and criteria do change from year to year

Building a Plan That Doesn't Depend on Medication Access

Whatever happens with NHI and public sector access over time, a solid nutrition and activity foundation helps regardless. Start with our full South African weight loss guide.

Read Our SA Weight Loss Tips

A Simple Way to Think About This

Public sector GLP-1 access today is limited and generally tied to diabetes management, varying by province and facility -- ask your local clinic directly
NHI's specific medicine formulary isn't finalised publicly yet -- follow the National Department of Health and SAHPRA for current, accurate updates
Private medical aid access isn't automatic either -- most schemes require a qualifying diagnosis and prior authorisation
If medication isn't accessible right now, structured eating, activity and working with your local healthcare provider remain effective, free-to-low-cost options
Revisit your options periodically -- both NHI rollout and medical aid formularies are subject to change

Bottom Line

GLP-1 access through South Africa's public healthcare system and the developing NHI is a genuinely unsettled area, and anyone promising a definitive timeline or guarantee isn't giving you the full picture. What's realistic today is limited, diabetes-focused access at state facilities that varies by province, with NHI's future approach still being worked out. In the meantime, effective weight management doesn't have to wait on medication access -- a solid eating and activity plan, built with your local healthcare provider, is a foundation worth starting regardless of what happens with future medicine coverage.

Medical disclaimer: This article is for general information only and is not a substitute for professional medical advice. Public healthcare policy, NHI implementation and medical aid formularies change over time and can vary by province, scheme and facility. Please consult your doctor, clinic, or the National Department of Health directly for current, personalised guidance, especially if you have diabetes or another condition requiring ongoing medication management.